Integrative Functional Genomics Implicated the Key T-/B-Cell Deficiency Regulator RAG1 in Transarterial Chemoembolization of Hepatocellular Carcinoma
Transarterial chemoembolization (TACE) has significantly prolonged overall survival (OS) of unresectable hepatocellular carcinoma (HCC) patients. Unfortunately, there are still a portion of patients without therapeutic responses to TACE. Although genome-wide association studies identified multiple H...
Main Authors: | Yeyang Xu, Teng Wang, Jiajia Zeng, Bowen Wang, Liqing Zhou, Ming Yang, Li Zhang, Nasha Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.720791/full |
Similar Items
-
Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
by: Liu KC, et al.
Published: (2020-08-01) -
Lipiodol retention pattern predicts transarterial chemoembolization therapeutic effect in hepatocellular carcinoma
by: Margaretha Vianny, et al.
Published: (2015-04-01) -
Lipiodol retention pattern predicts transarterial chemoembolization therapeutic effect in hepatocellular carcinoma
by: Margaretha Vianny, et al.
Published: (2016-02-01) -
Early experience of combination therapy of transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma measuring 3–7 cm
by: Yashwant Patidar, et al.
Published: (2019-01-01) -
PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma
by: Sean P. Martin, et al.
Published: (2020-06-01)